RxDoctor Payments Data

Ashrito Dayal, MD

Rheumatology · Charlotte, NCNPI 1306820105

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 210 rheumatology providers in North Carolina.

See all rheumatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$859,987
Medicare patients
458
Services billed
32,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab338$2,771,950
Orencia ClickjectAbatacept24$184,998
RinvoqUpadacitinib15$98,166
Enbrel SureclickEtanercept12$91,138
Actemra ActpenTocilizumab13$61,250
TymlosAbaloparatide18$48,188
MethotrexateMethotrexate Sodium682$16,456
Mycophenolate Mofetil20$5,231
Hydroxychloroquine Sulfate101$3,636
Celecoxib18$1,578
Leflunomide34$1,536
Allopurinol161$1,286
Pilocarpine Hcl16$1,214
Azathioprine31$1,019
Folic Acid75$966

Paid to pharmacies, not to this prescriber.

Other rheumatology in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →